2 results match your criteria: "Centers for Disease Control and Prevention Department of Health and Human Services[Affiliation]"
Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017.
JAMA
January 2021
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention Department of Health and Human Services, Atlanta, Georgia.
Importance: Substantial increases in both neonatal abstinence syndrome (NAS) and maternal opioid use disorder have been observed through 2014.
Objective: To examine national and state variation in NAS and maternal opioid-related diagnoses (MOD) rates in 2017 and to describe national and state changes since 2010 in the US, which included expanded MOD codes (opioid use disorder plus long-term and unspecified use) implemented in International Classification of Disease, 10th Revision, Clinical Modification.
Design, Setting, And Participants: Repeated cross-sectional analysis of the 2010 to 2017 Healthcare Cost and Utilization Project's National Inpatient Sample and State Inpatient Databases, an all-payer compendium of hospital discharge records from community nonrehabilitation hospitals in 47 states and the District of Columbia.
Estimating reusability of organic air-purifying respirator cartridges.
J Occup Environ Hyg
October 2011
National Institute for Occupational Safety and Health/Centers for Disease Control and Prevention/Department of Health and Human Services (NIOSH/CDC/DHHS), National Personal Protective Technology Laboratory, Pittsburgh, Pennsylvania, USA.
Reuse of organic vapor air-purifying respirator cartridges after a job or shift can provide economy and energy savings. However, standards and manufacturers' guidance discourage reuse, presumably due to a lack of quantitative objective exposure and use information. Storage and simulated reuse laboratory studies and modeling have been done to provide such information.
View Article and Find Full Text PDF